Showing 2041-2050 of 8160 results for "".
AK Therapy: Real-life Approaches to Combinations on Scientifically Speaking
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-therapy-real-life-approaches-to-combinations-on-scientifically-speaking/19913/From serial PDT to novel combinations, specialists describe how they treat AKs in real-world settings. Scientifically Speaking host Joel L. Cohen, MD reviews cases from Neal Bhatia, MD, Michael H. Gold, MD, and George Martin, MD.Patient Assessment: A Key to AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/patient-assessment-a-key-to-ad-care/19889/What is the Quality of Care in Atopic Dermatitis initiative, and why is it important? Dr. Stephan Weidinger shares his thoughts on the importance of this "impressive" program and offers suggestions to improve the assessment and care of patents with eczema.How Can I Reduce Irritation from Face Masks?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-can-i-reduce-irritation-from-face-masks/19824/Friction from masks can initiate an inflammatory response. Dr. Friedman explains how to reduce and prevent the inflammation with facial moisturizers and other tools.COVID-19 Impact: Navigating Clinical Research
https://practicaldermatology.com/series/dermatology-dispatches/covid-19-impact-navigating-clinical-research/19771/Conducting clinical research studies is challenging as the majority of Americans are under stay-at-home orders for the forseeable future due to the COVID-19 pandemic, says Todd E. Schlesinger, MD. He suggests trialists do their best to say in contact with clinical research organizations, sponsors, aSystemic Treatment for Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/systemic-treatment-for-skin-cancers/19662/Anisha B. Patel, MD discusses the latest advances in systemic treatment for melanoma with host Joshua Zeichner, MD. She reviews how treatments work, the most common cutaneous reactions patients experience, and the dermatologist's role in managing those reactions and reassuring patients that these reHot Topic: Medical Photography, EHRs, and Augmented Reality Technology
https://practicaldermatology.com/topics/practice-management/hot-topic-medical-photography-ehrs-and-augmented-reality-technology-/19568/Todd E. Schlesinger, MD and Joel L. Cohen discuss advances in the pipeline in terms of photo storage, search functionality in electronic medical records, and the emergence of augmented reality technology in patient and physician education.Treating Moderate to Severe Psoriasis: Weighing the Treatment Options
https://practicaldermatology.com/topics/psoriasis/-treating-moderate-to-severe-psoriasis-weighing-the-treatment-options/18375/In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that provide patients with moderate to severe psoriasis improved treatment options. She discusses their efficacy and safety and offers tips for finding the right one for each patient baCosmetic Controversies
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-controversies--fwjagege/18202/With the variety of devices on the market, aesthetic physicians may not even realize all the options available. They can reduce chin fat and cellulite, treat melasma, and even help patients build muscle. Jeanine Downie, MD discusses options.How to Use Email Effectively to Build Client Loyalty
https://practicaldermatology.com/topics/practice-management/email-loyalty/18218/Using email effectively can help you encourage client loyalty as well as client satisfaction. This Ekwa Marketing video explains how you can do this to optimize client experience and motivate clients to return.FDA Approvals, Acne Insights, EPI Gets Cloderm
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approvals-acne-insights-epi-gets-cloderm/18230/In a flurry of approvals, FDA gives the nod to Almirall's Seysara (sarecycline), Ortho Dermatologics' Bryhali (halobetasol propionate, 0.01%) Lotion, Paratek Pharmaceuticals' Nuzyra (omadacycline), and Regeneron's Libtayo (cemiplimab). Research shows top earners across various fields in the US may